Conceptualisation of a Network Approach to Complete the Classification of Eating Disorders With the Aim of Better Personalising Their Management
NCT ID: NCT06252688
Last Updated: 2024-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
840 participants
INTERVENTIONAL
2024-02-15
2031-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Clinical, Neuropsychological and Psychosocial Situation of Patient With Eating Disorders.
NCT02829645
Impact of Neuropsychological Alteration of Decision-making Abilities on the Functioning of Patients With Eating Disorders
NCT03160443
Developing Recommendations to Support Therapeutic Alliance in Eating Disorders Inpatient Treatment
NCT06961032
Impact of Neuropsychological Alteration of Patients With Eating Disorders
NCT04091477
Prevalence of Eating Disorder Symptomatology Among Outpatients Referred to Health Promotion from Somatic Hospital Departments
NCT05656859
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will recruit a total of 840 patients with an eating disorder in the university hospital of Montpellier.
\- Participation consists of a one-day visit with a multidisciplinary assessment. No action is specific to research except the biological collection for the constitution of a genetic bank. This is the usual management of patients with eating disorders addressed to our department.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants
All participants performed the same evaluation: clinical and neuropsychological assessment.
All of them are patients with an eating disorder.
Ambulatory cares in a day-hospital (Lapeyronie, Montpellier) specialized in the evaluation of eating disorders.
All patients assessed in the day-hospital will permormed the same evaluation :
* Blood sampling
* Calorimetry
* Osteodensotometry
* Psychiatric assement
* Endocrinologic assessment
* Dietetic assessment
* Neuropsychological assessment
* Self-questionnaires
With the patient agreement, a biological collection will be constituted. The objective is the subsequent study of biological factors involved in eating disorders (in particular genetic factors)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ambulatory cares in a day-hospital (Lapeyronie, Montpellier) specialized in the evaluation of eating disorders.
All patients assessed in the day-hospital will permormed the same evaluation :
* Blood sampling
* Calorimetry
* Osteodensotometry
* Psychiatric assement
* Endocrinologic assessment
* Dietetic assessment
* Neuropsychological assessment
* Self-questionnaires
With the patient agreement, a biological collection will be constituted. The objective is the subsequent study of biological factors involved in eating disorders (in particular genetic factors)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient aged from 15 to 65 years
* Patient who performs the day-hospital evaluation
* Patient affiliated to a French social security system
* Patient able to understand the nature, the aim and the methodology of the study
* For minor one of the legal guardians gave his consent
Exclusion Criteria
* Patient's refusal to participate
* Patient protected by law (guardianship or curatorship)\*
* Pregnant or nursing women. A dosage of βHCG will be performed to ensure the absence of pregnancy
15 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL23_0261
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.